Segantii Capital Management’s Biogen BIIB Stock Holding History

Segantii Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100,000	Closed	-$28.5M	–	168
2023 Q2	$28.5M	Buy	+100,000	New	+$29.8M	1.48%	17
2023 Q1	–	Sell	-40,000	Closed	-$11.1M	–	316
2022 Q4	$11.1M	Buy	40,000 +20,000	+100%	+$5.65M	0.4%	46
2022 Q3	$5.34M	Buy	+20,000	New	+$4.25M	0.15%	73
2022 Q1	–	Sell	-6,479	Closed	-$1.55M	–	624
2021 Q4	$1.55M	Hold	6,479	–	–	0.05%	164
2021 Q3	$1.83M	Hold	6,479	–	–	0.06%	132
2021 Q2	$2.24M	Buy	6,479 +211	+3%	+$63.9K	0.06%	150
2021 Q1	$1.75M	Sell	6,268 -5,900	-48%	-$1.59M	0.08%	126
2020 Q4	$2.98M	Buy	+12,168	New	+$3.14M	0.14%	69

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Segantii Capital Management's BIIB Position: Q3 2023 in Review

Segantii Capital Management sold out of Biogen (BIIB) in Q3 2023, closing a stake of 100,000 shares — an estimated $28.5M sold.

Segantii Capital Management first reported a position in BIIB in Q4 2020 and held it in 8 quarters. The position peaked at $28.5M in Q2 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

Segantii Capital Management reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
Segantii Capital Management sold 100,000 Biogen shares in Q3 2023, an estimated $28.5M.
Segantii Capital Management first reported a position in Biogen in Q4 2020 and held it in 8 quarters.
Segantii Capital Management's Biogen position peaked at $28.5M in Q2 2023.
965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Segantii Capital Management's 13F filing for Q3 2023, filed 7 Nov 2023.